Capmatinib Recruiting Phase 1 Trials for Colorectal Cancers / Renal Cell Adenocarcinoma / Glioblastoma Multiforme (GBM) / Gliosarcoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02386826INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme